Surgeons must carefully consider the etiology of any irregular astigmatism when deciding on treatments, according to Thomas Kohnen, MD.
A combination of a topical corticosteroid and a nonsteroidal anti-inflammatory drug (NSAID) is more effective than either one alone in reducing the risk of cystoid macular oedema (CME) after cataract surgery in nondiabetic patients, researchers say.
Patient selection is the key factor in obtaining the best visual outcomes after cataract surgery and intraocular lens implantation.
Because a variety of vision-limiting macular pathologies are detectable only with OCT, this imaging should be performed in all patients undergoing cataract surgery.
A new small-aperture intraocular lens (IOL) extends patients’ depth of focus as well as multifocal IOLs with fewer dysphotopsias, researchers say.
Scleral tunnel, “glued” fixation technique works better than alternative fixation techniques in cases where intraocular lenses (IOLs) cannot be placed in capsular bag or in the sulcus, according to Sumit Garg, MD.
Residual astigmatism is not uncommon after toric IOL implantation. Depending on its cause and magnitude, lens reorientation may be a good solution.
When it comes to recommending a premium IOL, a patient’s glaucoma is only one factor to consider. Just like any other patient planning cataract surgery, visual needs and preferences for/against glasses are also important factors.